RWA Wealth Partners’s Biogen BIIB Stock Holding History

RWA Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,056	Closed	-$708K	–	560
2024 Q2	$708K	Sell	3,056 -33	-1%	-$7.17K	0.01%	349
2024 Q1	$666K	Buy	3,089 +67	+2%	+$15.7K	0.01%	358
2023 Q4	$782K	Buy	+3,022	New	+$742K	0.01%	323
2018 Q3	–	Sell	-389	Closed	-$113K	–	281
2018 Q2	$113K	Buy	389 +343	+746%	+$96.4K	0.01%	307
2018 Q1	$13K	Buy	+46	New	+$14.3K	﹤0.01%	439

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RWA Wealth Partners's BIIB Position: Q3 2024 in Review

RWA Wealth Partners sold out of Biogen (BIIB) in Q3 2024, closing a stake of 3,056 shares — an estimated $708K sold.

RWA Wealth Partners first reported a position in BIIB in Q1 2018 and held it in 5 quarters. The position peaked at $782K in Q4 2023. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

RWA Wealth Partners reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
RWA Wealth Partners sold 3,056 Biogen shares in Q3 2024, an estimated $708K.
RWA Wealth Partners first reported a position in Biogen in Q1 2018 and held it in 5 quarters.
RWA Wealth Partners's Biogen position peaked at $782K in Q4 2023.
917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on RWA Wealth Partners's 13F filing for Q3 2024, filed 8 Nov 2024.